Matthew J McBride1,2,3, Cigall Kadoch1,2. 1. Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. 2. Broad Institute of MIT and Harvard, Cambridge, MA, USA. 3. Chemical Biology Program, Harvard University, Cambridge, MA, USA.
Abstract
Soft-tissue sarcomas are increasingly characterized and subclassified by genetic abnormalities that represent underlying drivers of their pathology. Hallmark tumor suppressor gene mutations and pathognomonic gene fusions collectively account for approximately one-third of all sarcomas. These genetic abnormalities most often result in global transcriptional misregulation via disruption of protein regulatory complexes which govern chromatin architecture. Specifically, alterations to mammalian SWI/SNF (mSWI/SNF or BAF) ATP-dependent chromatin remodeling complexes and polycomb repressive complexes cause disease-specific changes in chromatin architecture and gene expression across a number of sarcoma subtypes. Understanding the functions of chromatin regulatory complexes and the mechanisms underpinning their roles in oncogenesis will be required for the design and development of new therapeutic strategies in sarcomas.
Soft-tissue sarcomas are increasingly characterized and subclassified by n class="Disease">genetic abnormalities that represent underlying drivers of their pathology. Hallmark tumor suppressor gene mutations and pathognomonic gene fusions collectively account for approximately one-third of all sarcomas. These genetic abnormalities most often result in global transcriptional misregulation via disruption of protein regulatory complexes which govern chromatin architecture. Specifically, alterations to mammalian SWI/SNF (mSWI/SNF or BAF) ATP-dependent chromatin remodeling complexes and polycomb repressive complexes cause disease-specific changes in chromatin architecture and gene expression across a number of sarcoma subtypes. Understanding the functions of chromatin regulatory complexes and the mechanisms underpinning their roles in oncogenesis will be required for the design and development of new therapeutic strategies in sarcomas.
Authors: K M Sakamoto; K B Kim; A Kumagai; F Mercurio; C M Crews; R J Deshaies Journal: Proc Natl Acad Sci U S A Date: 2001-07-03 Impact factor: 11.205
Authors: Marc Ladanyi; Cristina R Antonescu; Denis H Leung; James M Woodruff; Akira Kawai; John H Healey; Murray F Brennan; Julia A Bridge; James R Neff; Frederic G Barr; Jeffrey D Goldsmith; John S J Brooks; John R Goldblum; Syed Z Ali; Janet Shipley; Colin S Cooper; Cyril Fisher; Björn Skytting; Olle Larsson Journal: Cancer Res Date: 2002-01-01 Impact factor: 12.701
Authors: J P Ginsberg; E de Alava; M Ladanyi; L H Wexler; H Kovar; M Paulussen; A Zoubek; B Dockhorn-Dworniczak; H Juergens; J S Wunder; I L Andrulis; R Malik; P H Sorensen; R B Womer; F G Barr Journal: J Clin Oncol Date: 1999-06 Impact factor: 44.544
Authors: Sooryanarayana Varambally; Saravana M Dhanasekaran; Ming Zhou; Terrence R Barrette; Chandan Kumar-Sinha; Martin G Sanda; Debashis Ghosh; Kenneth J Pienta; Richard G A B Sewalt; Arie P Otte; Mark A Rubin; Arul M Chinnaiyan Journal: Nature Date: 2002-10-10 Impact factor: 49.962
Authors: Matthew J McBride; John L Pulice; Hannah C Beird; Davis R Ingram; Andrew R D'Avino; Jack F Shern; Gregory W Charville; Jason L Hornick; Robert T Nakayama; Enrique M Garcia-Rivera; Dejka M Araujo; Wei-Lien Wang; Jen-Wei Tsai; Michelle Yeagley; Andrew J Wagner; P Andrew Futreal; Javed Khan; Alexander J Lazar; Cigall Kadoch Journal: Cancer Cell Date: 2018-05-31 Impact factor: 31.743
Authors: Marc Tischkowitz; Sidong Huang; Susana Banerjee; Jennifer Hague; William P D Hendricks; David G Huntsman; Jessica D Lang; Krystal A Orlando; Amit M Oza; Patricia Pautier; Isabelle Ray-Coquard; Jeffrey M Trent; Michael Witcher; Leora Witkowski; W Glenn McCluggage; Douglas A Levine; William D Foulkes; Bernard E Weissman Journal: Clin Cancer Res Date: 2020-03-10 Impact factor: 13.801
Authors: Benjamin A Nacev; Kevin B Jones; Andrew M Intlekofer; Jamie S E Yu; C David Allis; William D Tap; Marc Ladanyi; Torsten O Nielsen Journal: Nat Rev Cancer Date: 2020-08-11 Impact factor: 69.800
Authors: Esther Baranov; Matthew J McBride; Andrew M Bellizzi; Azra H Ligon; Christopher D M Fletcher; Cigall Kadoch; Jason L Hornick Journal: Am J Surg Pathol Date: 2020-07 Impact factor: 6.298